Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Shares of Align Technology Are Plummeting - Will This Trend Continue?

This afternoon we watched Align Technology drop -36.3% to a price of $129.63 per share. The Mid-Cap Specialty Industrial Machinery company is now trading -31.87% below its average target price of $190.29. Analysts have set target prices ranging from $140.0 to $220.0 per share for Align Technology, and have given the stock an average rating of buy.

The stock has an average amount of shares sold short at 4.9%, and a short ratio of 2.93. Since 6.68% of the company's shares are owned by insiders, we can infer that there is a degree of alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 94.8% of Align Technology's shares being owned by this investor type.

Institutions Invested in Align Technology

Date Reported Holder Percentage Shares Value
2025-03-31 Vanguard Group Inc 12% 8,441,592 $1,094,325,732
2025-03-31 Blackrock Inc. 8% 5,934,930 $769,374,617
2025-03-31 State Street Corporation 4% 2,994,113 $388,141,822
2025-03-31 Wellington Management Group, LLP 3% 2,030,804 $263,263,265
2025-06-30 Ninety One UK Ltd 3% 1,916,309 $248,420,706
2025-03-31 Geode Capital Management, LLC 3% 1,856,987 $240,730,499
2025-03-31 T. Rowe Price Investment Management, Inc. 3% 1,823,498 $236,389,153
2025-03-31 Citadel Advisors Llc 2% 1,610,636 $208,794,789
2025-03-31 Capital World Investors 2% 1,251,712 $162,265,678
2025-03-31 Invesco Ltd. 2% 1,219,715 $158,117,747

Besides an analyst consensus of strong upside potential, other market factors point to there being positive market sentiment on Align Technology.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS